Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From 3M
Positive Medtech Revenues Into H2, But M&A And IPOs May Wait
EY’s John Babitt provided a mid-year 2022 update on medtech investment trends, and the outlook for the industry going into 2023 in this commentary for In Vivo.
Medtech Industry Mourns US Rep. Jackie Walorski
Indiana Republican Congresswoman Jackie Walorski, who died in a car crash Wednesday, was a strong proponent of device industry priorities such as device tax repeal and Medicare coverage for innovative technologies.
3M Plans To Spin Off Health Care Business By The End Of 2023
The company’s health businesses include product lines worth nearly $9bn in annual sales. The deal is designed to allow both the new health care company and the “new 3M” to focus resources more efficiently on their separate priorities.
Roche Diagnostics Names Diagnostics Leader Schinecker As New CEO
The Swiss company is preparing for a smooth transition in 2023, appointing 20-year Roche veteran and diagnostic chief Thomas Schinecker as its next chief executive as Severin Schwan becomes chairman.
Company Information
- Industry
- Biotechnology
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
-
Medical Devices
- Consumables, Central Supplies
-
Diagnostic Imaging Equipment & Supplies
- X-ray
-
Digital Health
- Artificial Intelligence
- Other Names / Subsidiaries
-
- 3M Company
- Acelity L.P. Inc.
- Crawford Healthcare Holdings Limited
- Kinetic Concepts, Inc.
- M*Modal
- Minnesota Mining and Manufacturing
- Scott Safety
- Semfinder
- Systagenix Wound Management, Limited